title: Neurologic aspects of lymphoma and leukemias.
abstract: The lymphomas and leukemias are a heterogenous group of hematologic malignancies with protean manifestations. Neurologic sequelae of the diseases have been recognized since the time the conditions were first described in the mid-1800s. Although our understanding of the various presentations of these blood disorders evolved along with our knowledge of malignancies, accurate diagnosis can still be difficult. It is critical for neurologists to have a high index of clinical suspicion to appropriately recognize their heralding features. This review's focus is the relevant clinical neurologic features and diagnostic studies that identify leukemias and lymphomas affecting the nervous system.
authors.affiliation: Department of Neurology, Loyola University Medical Center, Maywood, IL, USA. Electronic address: mmcoyd@lumc.edu.
authors.forename: Matthew
authors.initials: M
authors.lastname: McCoyd
authors.affiliation: Department of Neurology, Loyola University Medical Center, Maywood, IL, USA; Leischner Institute for Medical Education, Loyola University Medical Center, Maywood, IL, USA.
authors.forename: Gregory
authors.initials: G
authors.lastname: Gruener
authors.affiliation: Department of Hematology, Medical College of Wisconsin, Milwaukee, WI, USA.
authors.forename: Patrick
authors.initials: P
authors.lastname: Foy
mesh_terms: D006801:Humans; D007938:Leukemia / Q000150:complications*; D008223:Lymphoma / Q000150:complications*; D009422:Nervous System Diseases / Q000209:etiology*
keywords: ALL (acute lymphoblastic leukemia); AML (acute myeloid leukemia); APL (acute promyelocytic leukemia); CLL (chronic lymphocytic leukemia); CML (chronic myelogenous leukemia); Hodgkin lymphoma; Leukemia; lymphoma; non-Hodgkin lymphoma